The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. - Wikidata - wikimedia - TriplyDB

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

http://www.wikidata.org/entity/Q33561725

about

Selective Insulin Resistance in the Kidney Cellular senescence in aging and age-related disease: from mechanisms to therapy Klotho, stem cells, and aging Fibrosis and renal aging Opposite action of peroxisome proliferator-activated receptor-gamma in regulating renal inflammation: functional switch by its ligand Diabetic nephropathy - Epidemiology in Asia and the current state of treatment Cells derived from young bone marrow alleviate renal aging.Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects.Protective effects of PPARγ agonist in acute nephrotic syndrome.Uncoupling protein-2 expression and effects on mitochondrial membrane potential and oxidant stress in heart tissue.Reduction of Oxidative Stress in Chronic Kidney Disease Does Not Increase Circulating α-Klotho Concentrations.Peroxisome proliferator-activated receptor-γ protects against vascular aging.Combination therapy with losartan and pioglitazone additively reduces renal oxidative and nitrative stress induced by chronic high fat, sucrose, and sodium intake.Differential Roles of Peroxisome Proliferator-Activated Receptor-α and Receptor-γ on Renal Crystal Formation in Hyperoxaluric Rodents MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways Clinic significance of markedly decreased α-klothoin women with preeclampsia Secreted klotho and chronic kidney disease High glucose represses β-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor γ signaling.Protective Effect of PPARγ Agonists on Cerebellar Tissues Oxidative Damage in Hypothyroid Rats.Pioglitazone Inhibits the Expressions of p22(phox) and p47(phox) in Rat Mesangial Cells In Vitro.PPARγ and chronic kidney disease.Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?PPARγ agonist beyond glucose lowering effect.Kidney aging--inevitable or preventable?The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes.New insights on molecular mechanisms of renal aging.Insulin signalling to the kidney in health and disease.Senescence suppressors: their practical importance in replicative lifespan extension in stem cells.Peroxisome proliferator activating receptor-γ and the podocyte.Oxidative stress-induced alterations in PPAR-γ and associated mitochondrial destabilization contribute to kidney cell apoptosis.Potential application of klotho in human chronic kidney disease.Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update.PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney.αKlotho and Chronic Kidney Disease.Antialbuminuric actions of calcilytics in the remnant kidney.Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes.Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects against Renal Fibrosis in 5/6 Nephrectomized Rats.Evaluation of Protein Kinase Cβ and PPARγ Activity in Diabetic Rats Supplemented with Momordica charantia Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis.

P2860

Q26744243-ABEB6C3C-39F7-43C5-A175-DBE761BEAA70 Q26773500-ADFF9D8D-86F7-41CD-9C2E-E1B4ADF2C18D Q26783185-61A846E3-BB56-4D0B-9F92-078777C41FD4 Q26796626-F33003AF-4C7E-48B8-B498-6A1FE6886957 Q28581020-0A87EC75-5E6C-406F-A0A3-98A22FD6C4B4 Q28742785-E4E25BC8-917E-4FD9-AF01-F8A15273AD7A Q34037439-4F700986-DFFE-4316-A8DC-88E7C7009690 Q34204949-00E9FFAC-8A70-4854-B73C-817D8C806ABB Q35188070-B4843714-381A-4D88-AED2-6605A1CB734E Q35747241-0DA948B5-6F5D-4E44-9BD7-EF2EAA226A3E Q35893254-22D0D452-3A9E-46C1-99AB-6EC97356E58E Q35903098-7FB7BEB3-8440-495A-8E2D-13B1430395AA Q35994295-48529795-D137-464D-80D3-34020ADCA08D Q36421284-68661787-6433-4568-A5CD-EFEF01D23CF4 Q36679676-CB75ED87-2232-43C4-99FF-AC0B16C792DF Q36901558-34132A3B-17C0-4DA7-922D-C6BE1BB88060 Q36964055-EC4F0E3C-17BD-4E60-AA6D-5B0AC3E49B84 Q37190542-A9638BAD-6054-442D-B3AB-2246E2E3ABD4 Q37251086-F03CE5EB-DC98-424B-9464-D598DE05E5EA Q37571681-2D26A4B3-862B-48F3-AE36-6B8C1F669E54 Q37594599-B450375E-C696-4F77-BC34-C12FBB621BB1 Q37777055-64E4EAB1-F7E6-41C7-AAA2-1601B9D2D023 Q37785713-100E1C6B-8439-4E23-81A2-1DF8E8D14950 Q37857704-04602FB5-018A-4CE1-8152-E8E4D6249042 Q37913979-859BF5AF-849D-4323-B129-4EA56F0D10B0 Q37997004-D09977B0-BBF2-4D9F-837D-6013778934D5 Q38033716-44A21F4C-F8E0-4A70-A3CE-4FFA2EFDC9E5 Q38063325-F7DDA4C7-59B0-455B-9891-1BE3AC66B34B Q38232804-292E9BB6-5DBB-47D2-B1C4-A1224C123200 Q38815188-C1B6A8E6-E32B-4B5D-AED0-9CC5FFA0C4D3 Q38966233-08258370-6849-4E42-9BDB-33A1D626F21E Q39003568-E5AD8053-76C1-48B2-8BFD-ABC561875E79 Q39158847-115671EE-DBA5-4E1D-8125-79B6E72202B0 Q39451549-9CC6969C-1045-4298-9C76-5C984A46B229 Q39812781-D3C53479-E538-43CA-B3D6-70B44308867C Q40896471-97633D44-73DD-447A-81DD-27BE78789E38 Q41004141-E5050D81-E79A-4BD3-B539-AAD3F2BF12A4 Q41437002-CC0F0A98-5E47-4A55-B7EB-0AA5154977D3 Q41518524-BBCBF455-5FE2-49DB-82D0-89903803B525 Q42707950-6A7A40B1-92D1-4BF7-B86F-0B4A6EE7B03F

P2860

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

http://www.wikidata.org/entity/Q33561725

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

@ast

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

@en

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

@nl

type

label

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

@ast

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

@en

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

@nl

prefLabel

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

@ast

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

@en

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

@nl

P1433

Q33561725-7B899874-6FE7-465F-ACF7-C7353F4DF866

P1476

Q33561725-A0056702-C8F2-4515-8109-882A2DED7AC9

P2093

Q33561725-09BED4E5-8918-4A3B-8FAF-B7412CA1B135

Q33561725-33BE0FF7-8CE0-4C66-A573-6A444992A358

Q33561725-51946BE6-CB7B-4DFF-87F7-6507B44EC329

Q33561725-5764CA00-762F-4BCF-BF3F-ADC415BEE707

Q33561725-E743B460-F292-43B8-A6E0-FBBEE1B3DC0B

Q33561725-ECE0ABA4-F600-44FF-B543-039E0C58E1BF

P2860

Q33561725-0213A54E-5955-42E3-87EA-662CC8A83260

Q33561725-10B5A725-D59D-497A-89BB-2C473CED5BEB

Q33561725-1BFB6C11-64FA-4A2C-A6F9-6BFA9BCED795

Q33561725-228701F8-282A-45E4-9151-DD27DF9CE059

Q33561725-2453D517-FC0C-4220-88B4-93E441333D59

Q33561725-290165DF-FBE7-45BA-BFAF-6F72B8015F4D

Q33561725-348A5E3E-9F32-4CD0-A227-324645367EB0

Q33561725-4054D8D2-48CC-4B44-BF5D-0CE1D2EE98A7

Q33561725-46CA15E5-B6A3-4132-8300-6C7CE6A0D01A

Q33561725-50A578B3-7CA1-4FFA-AF4E-F9252CADBBAF

P304

Q33561725-6C056D88-7C76-4F4C-8DFC-950D544473E8

P31

Q33561725-117282D4-C778-4C28-B226-7C833C55CA98

P356

Q33561725-B4D07981-A07A-4E64-A9FF-798292BDDDDC

P433

Q33561725-5427388B-3F9D-4D8E-A129-178D5CC99D12

P478

Q33561725-788D3ECC-5D1F-4C39-BC39-578CE0D9E2B1

P577

Q33561725-8AD6A4A6-375F-4158-8731-FC5376EADC46

P698

Q33561725-C3AB35A4-DE32-42F2-A8B0-A6F28D7394D1

P932

Q33561725-AB7FEF80-9FF0-476B-BDC8-77EA538BD981

P356

P1433

Journal of the American Society of Nephrology

P1476

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

@en

P2093

Agnes B Fogo

http://www.w3.org/2001/XMLSchema#string

Hai-Chun Yang

http://www.w3.org/2001/XMLSchema#string

Li-Jun Ma

http://www.w3.org/2001/XMLSchema#string

Sebastian A Potthoff

http://www.w3.org/2001/XMLSchema#string

Sebastien Deleuze

http://www.w3.org/2001/XMLSchema#string

Yiqin Zuo

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidants, antioxidants, and the degenerative diseases of aging

Troglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alpha

PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase

Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging

The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells.

The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells.

Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects.

The role of mitochondrial DNA mutations in mammalian aging

The biochemistry of aging.

Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells.

P304

2380-2388

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2008111138

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19797472

http://www.w3.org/2001/XMLSchema#string

P932

2799181

http://www.w3.org/2001/XMLSchema#string